UK markets closed

Biodesix, Inc. (BDSX)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.3600-0.0100 (-0.73%)
As of 01:03PM EDT. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-51,784
-43,159
-31,350
-30,726
-26,166
Depreciation & amortisation
3,620
3,178
2,903
2,793
1,740
Stock-based compensation
4,538
4,944
3,709
170
142
Change in working capital
11,949
4,591
-4,801
-1,645
253
Accounts receivable
14,632
11,454
-10,308
-3,646
-146
Accounts payable
-
-
-
1,193
342
Other working capital
-32,379
-30,770
-23,543
-23,142
-18,294
Other non-cash items
4,286
4,328
6,577
5,319
6,307
Net cash provided by operating activities
-29,996
-28,223
-21,366
-21,726
-17,677
Cash flows from investing activities
Investments in property, plant and equipment
-2,383
-2,547
-2,177
-1,416
-617
Acquisitions, net
-
0
-750
-456
0
Net cash used for investing activities
-2,383
-2,547
-2,927
-1,872
-617
Cash flows from financing activities
Debt repayment
-20,023
-45,428
-
0
-22,518
Common stock issued
18,472
16,671
72,000
-
-
Other financing activities
-5,522
-828
-8,249
-119
-283
Net cash used provided by (used for) financing activities
-6,523
1,262
81,131
22,972
19,032
Net change in cash
-38,902
-29,508
56,838
-626
738
Cash at beginning of period
55,415
62,306
5,468
6,094
5,356
Cash at end of period
16,513
32,798
62,306
5,468
6,094
Free cash flow
Operating cash flow
-29,996
-28,223
-21,366
-21,726
-17,677
Capital expenditure
-2,383
-2,547
-2,177
-1,416
-617
Free cash flow
-32,379
-30,770
-23,543
-23,142
-18,294